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Abstract
A 35 year-old asymptomatic Caucasian female with a family history of hypertrophic
cardiomyopathy (HCM) was referred for cardiologic evaluation. The electrocardiogram and
transthoracic echocardiogram were normal. Cardiovascular magnetic resonance (CMR) was
performed for further assessment of myocardial function and presence of myocardial scar. CMR
showed normal left ventricular systolic size, measurements and function. However, there was
extensive, diffuse late gadolinium enhancement (LGE) throughout the left ventricle. This finding was
consistent with extensive myocardial scarring and was highly suggestive of advanced, non-ischemic
cardiomyopathy. Genotyping showed a heterozygous mis-sense mutation (275G>A) in the cardiac
troponin T (TNNT2) gene, which is causally associated with HCM. There have been no previous
reports of such extensive, atypical pattern of myocardial scarring despite an otherwise structurally
and functionally normal left ventricle in an asymptomatic individual with HCM. This finding has
important implications for phenotype screening in HCM.
Case presentation
A 35 year-old asymptomatic Caucasian female with a sig-
nificant family history of hypertrophic cardiomyopathy
(HCM), including sudden cardiac death of unknown
cause in one son and HCM in two other children, was
referred for cardiologic consultation. The electrocardio-
gram and transthoracic echocardiogram had revealed no
abnormalities. Cardiovascular magnetic resonance
(CMR) was performed for further assessment of myocar-
dial function and detection of myocardial scar. Two-,
three- and four-chamber CMR cines were obtained using
steady-state free precession and inversion-recovery imag-
ing was used to assess late gadolinium enhancement
(LGE). CMR showed normal left ventricular (LV) systolic
function (end-systolic volume index 24 mL/m2; end-
diastolic volume index 72 mL/m2, ejection fraction 63%)
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and normal wall thickness (anteroseptal wall thickness
0.8 cm, posterolateral wall thickness 0.8 cm). There was
extensive, diffuse, poorly demarcated LGE throughout the
LV ventricle, predominantly involving the basal lateral,
basal anteroseptal and mid-inferior walls (figures 1A and
1B). Subsequent genotyping showed she was hetero-
zygous for the mis-sense mutation 275G>A (R92Q) in
exon 9 of the cardiac troponin T gene (TNNT2) previously
reported to be associated with HCM [1,2]. The same gene
defect was also found in both surviving children with
HCM.
Myocardial scar in HCM shows wide variation. Longitudi-
nal stripes of fibrosis commonly occur at the junctions of
the interventricular septum and free wall of the right ven-
tricle (right ventricular insertion points), but more
advanced forms include dense replacement scars through-
out the ventricle [3]. Myocardial scar in HCM may serve as
an arrhythmogenic substrate and the extent of area
involved has been shown an association with arrhyth-
mias, sudden cardiac death and major adverse cardiovas-
cular events [3-5]. Diffuse LGE on CMR without left
ventricular hypertrophy or enlargement is uncommon in
HCM. LGE represents myocardial fibrosis in HCM, and
therefore, with such diffuse pattern of myocardial scar-
ring, left ventricular function might be expected to be
depressed. The presence of diffuse LGE in a patient with
an unequivocal HCM genotype and family history in the
setting of an unequivocal normal cardiac phenotype has
not been reported previously. This indicates that cardiac
fibrosis may be the only demonstrable abnormality in
HCM, and precede other phenotypic expression in HCM.
This finding has important potential implications for fam-
ily screening in HCM. Further evaluation of the need to
include LGE CMR as routine practice to screen relatives of
patients with HCM is required.
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Inversion-recovery images in the vertical long-axis (2-cham- ber shown) view demonstrating diffuse, poorly demarcated  late-gadolinium enhancement (arrows) without left ventricu- lar enlargement or hypertrophy (LA – left atrium, LV – left  ventricle) Figure 1
Inversion-recovery images in the vertical long-axis 
(2-chamber shown) view demonstrating diffuse, 
poorly demarcated late-gadolinium enhancement 
(arrows) without left ventricular enlargement or 
hypertrophy (LA – left atrium, LV – left ventricle).
Inversion-recovery images in the vertical short-axis view  demonstrating diffuse, poorly demarcated late-gadolinium  enhancement (arrows) without left ventricular enlargement  or hypertrophy (LA – left atrium, LV – left ventricle) Figure 2
Inversion-recovery images in the vertical short-axis 
view demonstrating diffuse, poorly demarcated late-
gadolinium enhancement (arrows) without left ven-
tricular enlargement or hypertrophy (LA – left 
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